IL-17A-driven psoriasis is critically dependent on IL-36 signaling

IL-17A-driven psoriasis is critically dependent on IL-36 signaling

Plaque psoriasis is an autoinflammatory and autoimmune skin disease, affecting 1-3% of the population worldwide. Previously, high levels of IL-36 family cytokines were found in psoriatic skin lesions, thereby contributing to keratinocyte hyperproliferation and infiltration of immune cells such as ne...

Full description

Bibliographic Details
Main Authors:	Berenice Fischer, Tanja Kübelbeck, Antonia Kolb, Julia Ringen, Ari Waisman, Miriam Wittmann, Susanne Karbach, Stephan Marcus Kölsch, Daniela Kramer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Series:	Frontiers in Immunology
Subjects:	anti-IL36R psoriasis IL-17A keratinocytes imiquimod systemic inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1256133/full

Similar Items

Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis
by: Theresa Benezeder, et al.
Published: (2020-06-01)

IL36G is associated with cutaneous antiviral competence in psoriasis
by: You-Wang Lu, et al.
Published: (2022-09-01)

Corrigendum: IL36G is associated with cutaneous antiviral competence in psoriasis
by: You-Wang Lu, et al.
Published: (2022-10-01)

Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4/IL-36R Crosstalk
by: Shuai Shao, et al.
Published: (2019-04-01)

Evaluating Serum Levels of IL-33, IL-36, IL-37 and Gene Expression of IL-37 in Patients with Psoriasis Vulgaris
by: Mojtaba Sehat, et al.
Published: (2018-04-01)

Comparative Analysis of Single-Cell Transcriptome Data Reveals a Novel Role of Keratinocyte-Derived IL-23 in Psoriasis
by: Young Joon Park, et al.
Published: (2022-05-01)

IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis
by: Charlie Bridgewood, et al.
Published: (2018-02-01)

Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis
by: Guo J, et al.
Published: (2019-02-01)

Effect of YangxueJiedu Decoction on the expression levels of IL-36 in psoriasis-like lesions in mice
by: Qi ZHANG, et al.
Published: (2021-06-01)

The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab
by: Jason E. Hawkes, et al.
Published: (2023-11-01)

Polymorphisms in IL36G gene are associated with plaque psoriasis
by: Tanel Traks, et al.
Published: (2019-01-01)

The LINC01176-miR-218-5p-IL-36G Network is Responsible for the Pathogenesis of Psoriasis by Promoting Inflammation
by: Zhao Z, et al.
Published: (2024-01-01)

Identification of small‐molecule elastase inhibitors as antagonists of IL‐36 cytokine activation
by: Graeme P. Sullivan, et al.
Published: (2018-05-01)

IkBζ is a Key Regulator of Tumour Necrosis Factor-a and Interleukin-17A-mediated Induction of Interleukin-36g in Human Keratinocytes
by: Sofie Kaas Ovesen, et al.
Published: (2021-02-01)

Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development
by: Dawn Queen, et al.
Published: (2019-12-01)

Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels
by: Chen Y, et al.
Published: (2024-11-01)

Establishment of an Intradermal Ear Injection Model of IL-17A and IL-36γ as a Tool to Investigate the Psoriatic Cytokine Network
by: David Kluwig, et al.
Published: (2021-08-01)

Serum Levels of IL-10 and IL-22 Cytokines in Patients with Psoriasis
by: Mohammad Reza Sobhan, et al.
Published: (2016-12-01)

Role of IL-1 Family Cytokines IL-36, IL-37, IL-38 in Osteoarthritis and Rheumatoid Arthritis: A Comprehensive Review
by: Xu Y, et al.
Published: (2024-06-01)

IWR-1 attenuates the promotional effect of IL-36γ in a mouse model of psoriasis
by: Wen-Ming Wang, et al.
Published: (2024-11-01)

Generalized pustular psoriasis in a toddler with IL36RN mutation: a case report
by: Ghaith Adi, et al.
Published: (2024-03-01)

The role of IL-36 and 37 in hepatocellular carcinoma
by: Juan Cao, et al.
Published: (2024-01-01)

New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors
by: João Vilaça, et al.
Published: (2024-07-01)

Ameliorating Effect of Oral Guggulsterone Administration in Imiquimod-Induced Psoriasis in Mice
by: Raghad A. Khaleel, et al.
Published: (2018-12-01)

Consideration of serum IL‐36α and β levels trends in two patients with chikungunya fever
by: Makoto Kondo, et al.
Published: (2023-07-01)

Aberrant Expression of Three New Members of IL-1 Family (IL-36α, IL-37 and IL-38) in Patients with Multiple Sclerosis
by: Forouzan Ahmadi Khoei, et al.
Published: (2023-07-01)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
by: Nicolo Costantino Brembilla, et al.
Published: (2018-08-01)

The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
by: Xiaofang Wang, et al.
Published: (2021-05-01)

A Study Correlation between Levels IL-15, IL-23 and TNF-α in a Sample of Iraqi Psoriasis Patients
by: Samara Amar Sabri, et al.
Published: (2024-01-01)

IL‐36γ and IL‐36Ra Reciprocally Regulate Colon Inflammation and Tumorigenesis by Modulating the Cell–Matrix Adhesion Network and Wnt Signaling
by: Wei Yang, et al.
Published: (2022-04-01)

Serum concentrations of 25-OH vitamin D and the pro-inflammatory interleukins IL-17, IL-23, and IL-18 in patients with plaque psoriasis
by: Maria Ganeva, et al.
Published: (2024-06-01)

Case report: Infantile generalized pustular psoriasis with IL36RN and CARD14 gene mutations
by: Xinyun Tong, et al.
Published: (2023-01-01)

IL-1α and IL-36 Family Cytokines Can Undergo Processing and Activation by Diverse Allergen-Associated Proteases
by: Valentina Frezza, et al.
Published: (2022-06-01)

Structural Basis of IL-1 Family Cytokine Signaling
by: James K. Fields, et al.
Published: (2019-06-01)

The new external drug for the treatment of psoriasis based on inhibition of serine proteases
by: Alexander S. Zhukov, et al.
Published: (2021-07-01)

IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
by: Feier Chen, et al.
Published: (2020-02-01)

Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series
by: Chang-Yu Hsieh, et al.
Published: (2024-05-01)

A non-clinical comparative study of IL-23 antibodies in psoriasis
by: Li Zhou, et al.
Published: (2021-01-01)

Case report: Successful treatment with spesolimab of acrodermatitis continua of Hallopeau in an older patient without IL36RN mutations
by: Jianfeng Zheng, et al.
Published: (2025-01-01)

Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis)
by: Mario Valenti, et al.
Published: (2025-12-01)